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Research
Urban pollution, especially by particu-
late matter (PM), contributes to respiratory 
and cardiovascular morbidity and mortality 
(Dominici et al. 2006; Maitre et al. 2006; 
Pope et al. 2002; Simkhovich et al. 2008). 
To a large extent, the increase in mortality 
linked to PM ≤ 10 µm in aerodynamic diam-
eter (PM10) is attributable to cardiovascular 
diseases (Maitre et al. 2006; Nawrot et al. 
2006). Persons with diabetes who also have 
cardiovascular disease appear to be more sen-
sitive to the effects of air pollution on daily 
mortality (Goldberg et al. 2006). Zanobetti 
and Schwartz (2002) also found stronger 
associations between increased levels of PM 
and hospitalizations for heart disease among 
those who had diabetes compared with those 
who did not. The risk of coronary heart dis-
ease, stroke, and peripheral arterial disease 
is increased in persons with diabetes (Brand 
et al. 1989; Stamler et al. 1993). Both athero-
sclerosis and thrombosis appear to contribute 
to this increased cardiovascular risk (Colwell 
1997; Colwell and Nesto 2003). Therefore, 
research on environmental factors that may 
aggravate the disease, and on the mechanisms 
underlying this, has substantial public health 
relevance.
One of the problems in epidemiologic 
studies is estimating individual exposure to 
PM. In this study, the chronic exposure to PM 
was estimated at an individual level by deter-
mining the carbon load of airway macrophages, 
as described by Kulkarni et al. (2006). This 
approach is based on the fact that airway mac-
rophages are the primary phagocytotic cells of 
inhaled PM. The amount of carbonaceous PM 
extracted from the lung at autopsy reflects the 
chronic exposure to PM (Brauer et al. 2001). 
We hypothesized that exposure to PM causes 
prothrombotic changes in persons with diabe-
tes, possibly via systemic inflammation.
Materials and Methods
Study Population
Persons with both type 1 and type 2 diabetes 
were consecutively recruited from the diabetes 
outpatient clinic at the University Hospital 
Leuven. This clinic is a dedicated clinic for the 
routine 3- to 6-month follow-up of patients 
with diabetes. All patients were invited to par-
ticipate on days when the investigator was pres-
ent. They were included if they were ≥ 18 years 
of age and were nonsmokers. The study was 
carried out on different days from February 
2007 through September 2008. On the study 
day, patients completed a questionnaire to 
obtain information on age, occupation, socio-
economic status, exposure to environmental 
tobacco smoke, alcohol use, use of medication, 
use of oral contraception, menopausal status, 
place of residence, and means of transporta-
tion to the hospital. Socioeconomic status was 
coded and condensed into a scale with scores 
ranging from 1 to 3. Use of antiplatelet medi-
cation was coded as use of either none or one 
or more of the following substances: acetylsali-
cylic acid, clopidogrel, ticlopidine, or dipyri-
damole. Distances from the home address to 
major roads were calculated through geocod-
ing. Living close to a major road was defined as 
living within 100 m of an N-road or an E-road 
(Hoffmann et al. 2007).
Of the 186 recruited subjects, 137 (74%) 
took part in the examination (Figure 1). The 
49 patients that did not participate had the 
same age and sex distribution as the 137 
participants. Sufficient numbers of airway 
macrophages to assess the area occupied by 
carbon were obtained from 80 of the 119 
patients (18 of the 137 patients failed to pro-
duce sputum). A blood sample could not be 
obtained from 11 subjects, and platelet func-
tion analysis was not successful in 28 subjects. 
Ultimately, 63 subjects had data for both the 
carbon load of airway macrophages and the 
platelet function analysis.
The Ethics Review Board of the Medical 
Faculty of the University of Leuven approved 
the study. Participants gave informed consent 
at recruitment.
Exposure Assessment 
Ambient PM. Recent exposure. A portable 
laser-operated aerosol mass analyzer (Aerocet 
531; Met One Instruments Inc., Grants Pass, 
Address correspondence to B. Nemery, K.U. Leuven, 
Occupational and Environmental Medicine and 
Pneumology, Unit of Lung Toxicology, Herestraat 
49  (O&N  706),  B-3000  Leuven,  Belgium. 
Telephone: 32-16-347121. Fax: 32-16-347124. 
E-mail: ben.nemery@med.kuleuven.be
The studies of the Flemish Center of Expertise on 
Environment and Health were commissioned, financed, 
and steered by the Ministry of the Flemish Community 
(Department of Economics, Science and Innovation; 
Flemish Agency for Care and Health; Department 
of Environment, Nature and Energy). T.S.N. is the 
recipient of a grant of the Flemish Fund for Scientific 
Research (FWO-Vlaanderen, krediet aan navorsers).
The authors declare they have no competing 
  financial interests.
Received 4 May 2009; accepted 22 October 2009.
Air Pollution–Related Prothrombotic Changes in Persons with Diabetes
Lotte Jacobs,1 Jan Emmerechts,2 Chantal Mathieu,3 Marc F. Hoylaerts,2 Frans Fierens,4 Peter H. Hoet,1 
Benoit Nemery,1 and Tim S. Nawrot1,5
1Occupational and Environmental Medicine, Unit of Lung Toxicology, 2Center for Molecular and Vascular Biology, and 3Department 
of Endocrinology, Katholique Universiteit Leuven, Leuven, Belgium; 4Belgian interregional Environment Agency, Brussels, Belgium; 
5Centre for Environmental Sciences, Hasselt University, Diepenbeek, Belgium
ba c K g r O u n D: Population studies suggest that persons with diabetes are more sensitive to the 
effects of particulate matter (PM) air pollution. However, the biological mechanisms of a possible 
prothrombotic effect underlying this enhanced susceptibility remain largely unknown.
Ob j e c t i v e: We hypothesized that exposure to PM causes prothrombotic changes in persons with 
diabetes, possibly via systemic inflammation.
Me t h O D s : Our study included 137 nonsmoking adults with diabetes who were outpatients at the 
University Hospital Leuven. Recent exposure (2 hr before examination) to ambient PM was mea-
sured at the entrance of the hospital. Individual chronic exposure to PM was assessed by measuring 
the area occupied by carbon in airway macrophages obtained by sputum induction. Platelet func-
tion was measured ex vivo with the PFA-100 platelet function analyzer, which simulates a damaged 
blood vessel; we analyzed the function of platelets in primary hemostasis under high shear condi-
tions. Total and differential blood leukocytes were counted.
re s u l t s: Independent of antiplatelet medication, an interquartile range (IQR) increase of 
39.2 µg/m3 in PM10 (PM with aerodynamic diameter ≤ 10 µm) concentration measured 2 hr before 
the clinical examination (recent exposure) was associated with a decrease of 21.1 sec [95% confi-
dence interval (CI), –35.3 to –6.8] in the PFA-100 closure time (i.e., increased platelet activation) 
and an increase in blood leukocytes of 512 per microliter of blood (95% CI, 45.2–979). Each area 
increase of 0.25 µm2 (IQR) in carbon load of airway macrophages (chronic exposure) was associated 
with an increase of 687 leukocytes per microliter of blood (95% CI, 224–1,150).
cO n c l u s i O n s: A relevant increase in recent PM exposure was associated with a change in platelet 
function toward a greater prothrombotic tendency. The magnitude of the change was about two-thirds 
(in the opposite direction) of the average effect of antiplatelet medication. Diabetic patients showed 
evidence of proinflammatory response to both recent and chronic exposure to PM air pollution.
Key w O r D s : air pollution, diabetes, platelet function, systemic inflammation. Environ Health 
Perspect 118:191–196 (2010).  doi:10.1289/ehp.0900942 available via http://dx.doi.org/ [Online 
22 October 2009]Jacobs et al.
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OR, USA) was used to measure PM2.5 (PM 
with an aerodynamic diameter ≤ 2.5 µm) and 
PM10 concentrations 2 hr before the patient’s 
participation in the study. The device had been 
previously calibrated against a local monitor-
ing station (Flemish Environmental Agency, 
Borgerhout, Antwerp). The PM concentrations 
were measured both outside, at the entrance of 
the hospital, and inside, in the waiting room.
Modeled PM10. We calculated the 
regional background level of PM10 (previous 
day, week, month, 3 months, and 6 months 
and annual average) for each participant’s 
home address using a kriging interpolation 
method (Janssen et al. 2008). This model 
provides interpolated PM10 values from the 
Belgian telemetric air quality networks in 
4 × 4 km grids. The interpolation was based 
on a detrended kriging interpolation model 
that uses land cover data obtained from sat-
ellite images (Corine land cover data set; 
European Environment Agency 2000).
Internal PM: carbon load of airway 
macrophages obtained by induced sputum. 
To induce sputum, nebulized saline (NaCl 
3%, 4%, or 5%) was administered through 
an ultrasonic nebulizer (Ultra-NebTm2000 
model 200HI; DeVilbiss Healthcare, 
Somerset, PA, USA) in one, two, or three 
7-min inhalation periods. Patients were pre-
treated with an inhaled β2-agonist (200 µg 
salbutamol). Pulmonary function was meas-
ured before each inhalation period for the 
detection of clinically significant broncho-
constriction (Paggiaro et al. 2002). To iso-
late airway macrophages, induced sputum was 
processed according to a standard technique 
(Pizzichini et al. 1996). Dithiothreitol (Sigma 
Aldrich, St. Louis, MO, USA) was used as a 
mucolytic agent, and airway cells were cyto-
centrifuged (Cytospin; Shandon Scientific, 
Techgen, Zellik, Belgium) onto glass slides 
and stained with Diff-Quick (Medion 
Diagnostics, Düdingen, Germany). Sputum 
supernatants were kept at –80°C for future 
analysis. Airway macrophages (Figure 2) were 
visualized by light microscopy (AxioPlan 2 
Imaging; Zeiss, Zaventem, Belgium). Each air-
way macrophage was initially processed using 
Paint Shop software (version 5.1; Microsoft, 
Zaventem, Belgium). First, the nucleus was 
removed from the image. Then Scion image 
software (Scion Corporation, Frederick, MD, 
USA) was used to calculate the carbon load of 
airway macrophages, which was defined as the 
median area (square micrometers) occupied by 
carbon, in 50 randomly selected macrophages 
per patient (Kulkarni et al. 2005, 2006).
Clinical Measurements
Blood collection and analysis. A nonfasting 
blood sample was collected in an EDTA tube 
and in a tube containing 0.129 M (3.8%) 
sodium citrate for platelet function analysis 
and for differential cell counts, respectively. 
Blood cell counts (including platelet counts) 
and differential leukocyte counts were deter-
mined using an automated cell counter with 
flow differential (Cell Dyn 3500; Abbott 
Diagnostics, Abbott Park, IL, USA). Blood 
glucose levels and glycated hemoglobin were 
measured according to standard clinical pro-
cedures. Plasma samples were kept frozen at 
–80°C for future analysis.
Platelet function analyzer. Platelet function 
was assessed with the PFA-100 platelet func-
tion analyzer (Siemens Healthcare Diagnostics, 
Deerfield, IL, USA). The PFA-100 test car-
tridge consists of a capillary, a blood sample 
reservoir, and a membrane coated with colla-
gen/epinephrine with a central aperture. Whole 
blood is aspirated through the capillary and 
the aperture, thus exposing platelets to high 
shear rates (5,000/sec) and to collagen and epi-
nephrine, causing platelet activation. A platelet 
thrombus forms at the aperture, thus gradually 
diminishing and finally arresting blood flow. 
The time from the start of aspiration until the 
aperture completely occludes, that is, the clo-
sure time, reflects platelet aggregation in a shear 
stress–dependent way (Kundu et al. 1995).
Statistical Analysis
For database management and statistical analy-
sis, we used SAS software (version 9.1; SAS 
Institute Inc., Cary, NC, USA). For compari-
son of means, medians, and proportions, we 
applied the Student t-test, Wilcoxon test, and 
the chi-square statistic, respectively. We investi-
gated associations between markers of exposure 
(ambient PM10, PM2.5, and carbon load of 
airway macrophages) and different end points 
(platelet function, total and differential leu-
kocyte counts, platelet count) using multiple 
linear regression. We report results of unad-
justed analyses (in figures), results adjusted for 
age, and results of fully adjusted models. For 
fully adjusted models, covariates were identi-
fied by a stepwise regression procedure, with 
the p-values for variables to enter and to stay 
in the model set at 0.10. Covariates considered 
for entry in the model were age, sex, body mass 
index (BMI), socioeconomic status, outdoor 
temperature, time in traffic on the day of the 
examination, means of transportation to exam-
ination, time in hospital before blood draw, 
hour of blood draw, use of alcohol, exposure 
to environmental tobacco smoke, blood glu-
cose level, glycated hemoglobin, menopausal 
status, oral contraception, use of statins, use of 
angiotensin-  converting–    enzyme (ACE) inhibi-
tors, and use of antiplatelet medication. The 
possible effect modification of type of diabetes 
on the associations was studied. Regardless of 
the p-value, the type of diabetes was forced 
into the regression models. In a sensitivity anal-
ysis, we ran a model in which age, sex, BMI, 
and hour of blood draw were further forced 
into the models. Further, we calculated partial 
Spearman rank correlation coefficients for non-
normally distributed variables. Q–Q plots of 
the residuals were used to test the assumptions 
of all linear models.
Figure 1. Flowchart of study population, consecu-
tively recruited from the diabetes outpatient clinic 
at the University Hospital Leuven. Patients were 
included if they were ≥ 18 years of age and non-
smokers; 63 subjects had data on both platelet 
function (measured by PFA-100 platelet function 
analyzer) and carbon load of airway macrophages.
225 patients contacted
186 fulﬁlled inclusion
criteria (83%)
137 participated
 (74%)
49 refused
 (26%)
• Blood sample 126 (92%)
PFA: 98 (78%)
• Sputum sample 119 (87%)
Carbon load: 80 (67%)
39 excluded (17%)
• 9 pregnant (23%)
• 30 smokers (78%)
Figure 2. Airway macrophages with no (left), medium (middle), and high (right) carbon load. Airway mac-
rophages were obtained by induced sputum, stained with Diff-Quik, and viewed with light microscopy. 
The area occupied by carbon in 50 randomly selected airway macrophages was determined by means of 
image analysis, and the median area (µm2) per cell was calculated. Bar = 20 µm.Air pollution and prothrombotic changes
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Results
Characteristics of study participants. We found 
no major differences between the total group 
of participants (n = 137) and those that had a 
complete set of measurements (PFA-100 and 
carbon load, n = 63) (Table 1). In those who 
consumed alcohol, the median alcohol con-
sumption was 10 g/day [interquartile range 
(IQR), 22.5 g/day]. Forty women (63%) 
reported menopause, and eight (13%) used oral 
contraceptives. Among the men, 29 (40%) had 
type 1 diabetes, compared with 31 (48%) of the 
women. All patients with type 1 diabetes used 
insulin, whereas 77 persons (92%) of patients 
with type 2 diabetics used insulin medication. 
Eighty patients had important underlying car-
diovascular disease. We found no significant 
differences in the demographic variables or in 
the distance from the hospital to the patient’s 
residence (32.7 vs. 30.4 km, p = 0.57) between 
patients for whom we obtained sufficient 
numbers of airway macrophages (n = 80) and 
those for whom we did not (n = 57). Outdoor 
mean ± SD PM10 measured at the entrance 
of the hospital on the day of the patient’s visit 
was 56.1 ± 29.0 µg/m3, and the average indoor 
PM10 concentration measured in the waiting 
room was 36.6 ± 18.4 µg/m3. Transportation 
to the hospital was by car for 87% of the 
patients and by public transport (bus) for 13%. 
The average distance from the patient’s home 
address to the hospital was 31.3 km (range, 
0.7–139 km). The corresponding travel time 
was 26.2 min (range, 1–97 min).
Carbon load of airway macrophages. The 
carbon load of airway macrophages did not 
correlate with age or BMI. We found no 
significant difference in carbon load of mac-
rophages between men and women. Carbon 
load in macrophages was not associated with 
the recent outdoor or indoor PM10. However, 
persons living near a major road (< 100 m) 
had higher carbon load than did those living 
farther from a major road (0.29 vs. 0.17 µm2; 
p = 0.04). Each increase in modeled 6-month 
average PM10 at the participant’s residence was 
associated with an increase in the carbon load 
of airway macrophages (r = 0.30, p = 0.008), 
confirming that carbon load is a good marker 
of chronic exposure to PM.
Platelet function. The PFA-100 closure 
time was 30.4 sec [95% confidence interval 
(CI), 12.3–48.5, p = 0.001] higher in patients 
on antiplatelet therapy than in those not tak-
ing antiplatelet medication (n = 55). None of 
the other studied potential covariates, includ-
ing hour of blood draw, number of platelets, 
outdoor temperature, and travel time to the 
hospital, entered the stepwise regression model. 
Both before adjustment (Figure 3) and after 
adjustment (Table 2) for the use of anti  platelet 
medication, the closure time was inversely asso-
ciated with the recent outdoor PM measured 
2 hr before the examination, but not with 
indexes of chronic exposure. The interaction 
terms between use of antiplatelet medication 
and exposure to PM did not reach statistical 
significance (p ≥ 0.17). We observed no asso-
ciation between closure time and carbon load 
(chronic exposure). In a model combining 
recent exposure to PM10 and carbon load of air-
way macrophages (Table 3), the recent exposure 
remained negatively associated with the closure 
time. Forcing age, sex, BMI, and hour of blood 
draw into the stepwise regression models did 
not alter the reported findings significantly.
Total and differential blood leukocyte 
counts. In a stepwise multiple regression, the 
number of blood leukocytes was significantly 
higher in persons with type 2 diabetes than in 
those with type 1 diabetes (767/µL; 95% CI, 
77–1,456; p = 0.03) and increased with blood 
glucose (4.5/µL per mg/dL glucose; 95% CI, 
–0.3 to 9.4; p = 0.07). Both before adjustment 
(Figure 3) and after adjustment (Table 2) for 
these covariates, the number of leukocytes cor-
related positively both with recent exposure 
and with carbon load of airway macrophages. 
Even in a model that combined recent exposure 
to PM10 and chronic exposure (Table 3), as 
assessed by the carbon load of macrophages, the 
chronic exposure remained positively associ-
ated with the total number of leukocytes. The 
blood lymphocyte count showed a stronger 
association with the carbon load of airway mac-
rophages than with recent exposure to PM10, 
whereas blood neutrophils were only marginally 
associated with the carbon load but significantly 
with recent exposure (Table 2). This was also 
the case in the combined analysis (Table 3). 
We observed no significant changes in blood 
eosinophils and monocytes (data not shown).
In further analyses, we studied the asso-
ciations between platelet function and total 
blood leukocyte count. Number of leukocytes 
was not associated with platelet function, even 
not after adjusting for the carbon load of air-
way macrophages. Forcing age, sex, BMI, and 
hour of blood draw into the stepwise regres-
sion models did not alter the reported find-
ings significantly.
Blood platelet count. We found no asso-
ciation between blood platelets and markers of 
recent exposure to PM (Table 2). The carbon 
load was marginally associated with the num-
ber of blood platelets (Table 2). In a model 
(Table 3) with both recent (PM10) and chronic 
exposure (carbon load), only the chronic 
Table 1. Patient characteristics.
Characteristic
Total group  
(n = 137)
Group with carbon load 
and PFA-100 (n = 63)
Anthropometrics
Sex (female) 64 (47) 35 (56)
Age (years) 54.7± 14.4 51.5 ± 14.5
BMI (kg/m2) 28.4 ± 5.4 28.0 ± 5.2
Type 1 diabetes 60 (44) 29 (46)
Blood glucose (mg/dL) 145 ± 71.9 151.7 ± 72.7
Glycated hemoglobin (%) 7.4 ± 1.0 7.4 ± 1.1
Lifestyle
Regular alcohol use 36 (26) 18 (29)
Exposure to environmental tobacco smoke 27 (20) 10 (16)
Socioeconomic status
Low 79 (58) 32 (51)
Middle 44 (32) 21 (33)
High 14 (10) 10 (16)
Use of medication
Antiplatelet medicationa 82 (60) 34 (54)
Statins 88 (64) 37 (59)
ACE inhibitor 60 (44) 21 (33)
Insulin   130 (95) 61 (97)
Antidiabetic medication 50 (36) 21 (33)
Exposure markers
Recent (2 hr) outdoor PM2.5 (µg/m3) 25.1 ± 18.4 23.7 ± 16.0
Recent (2 hr) outdoor PM10 (µg/m3) 56.1 ± 29.0 53.2 ± 24.8
Six-month average modeled PM10 (µg/m3) 25.3 ± 3.7 25.4 ± 3.9
Carbon load in airway macrophages (µm2) 0.19 (0.09–0.34)b 0.20 (0.10–0.34)
End points
PFA-100 closure time (sec) 140 ± 47.9c 144 ± 50.4
Total blood leukocytes/µL 6,152 ± 2,027d 6,010 ± 2,134
Blood neutrophils/µL 3,826 ± 1,378d 3,706 ± 1,371
Blood eosinophils/µL 164 ± 138d 169 ± 163
Blood monocytes/µL 420 ± 157d 417 ± 151
Blood lymphocytes/µL 1,170 ± 739d 1,783 ± 697
Blood platelets ×103/µL 232 ± 62.4d 232 ± 60
Values are number (%) or arithmetic mean ± SD, except for the carbon load, which was not normally distributed, for 
which the median (IQR) is given. 
aAntiplatelet medication included acetylsalicylic acid, clopidogrel, ticlopidine, or dipyridamole. bData available for 80 
subjects. cData available for 98 subjects. dData available for 126 subjects.Jacobs et al.
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exposure was associated with number of blood 
platelets. Forcing age, sex, BMI, and hour of 
blood draw into the stepwise regression models 
did not alter the reported findings significantly.
Sensitivity analyses. Calculation of partial 
Spearman rank correlation coefficients for 
non-normally distributed variables confirmed 
our results (data not shown).
We studied possible effect modification 
of type of diabetes on the associations. The 
interaction term did not reach statistical sig-
nificance in any of the models (p > 0.20).
Models in which we replaced the carbon 
load of airway macrophages with the modeled 
6-month average PM air pollution near the 
patient’s home (4 × 4 km grid) showed no 
significant correlation with the studied effect 
parameters.
Discussion
We observed that PM exposure appears to 
have a rapid prothrombotic effect on plate-
let function. Recent and chronic exposures to 
PM were associated with markers of systemic 
inflammation, seen as an increase in blood leu-
kocyte counts. However, we found no asso-
ciation between the observed prothrombotic 
effect and markers of systemic inflammation. 
Currently, it is well recognized that thrombosis 
underlies most acute complications of athero-
sclerosis, such as acute myocardial infarction. 
Peters et al. (2001) showed that exposure to 
elevated concentrations of fine PM (PM2.5) for 
as little as 2 hr increases the risk of myocardial 
infarction. Long-term exposure to PM has also 
been suggested to play a role in the underlying 
pathologic process, atherosclerosis (Hoffmann 
et al. 2007; Künzli et al. 2005; Sun et al. 2005). 
The purpose of our study was not to show that 
persons with diabetes are more susceptible to 
the effects of PM air pollution, but to verify 
the hypothesis that PM causes prothrombotic 
Table 2. Change in platelet function and in total or differential blood leukocyte counts and platelet count for an IQR increase in recent outdoor PM2.5 or PM10 
concentrations or in carbon load of airway macrophages (separate analysis).
End point Exposure marker, IQR
Age-adjusted  
difference (95% CI) p-Value
Adjusteda  
difference (95% CI) p-Value
PFA-100 closure time (sec) PM2.5, 22.3 µg/m3 –12.4 (–25.8 to 1.0) 0.07 –16.3 (–29.0 to –3.7) 0.01
PM10, 39.2 µg/m3 –19.0 (–34.1 to –3.8) 0.02 –21.1 (–35.3 to –6.8) 0.005
Carbon load, 0.25 µm2 3.2 (–12.7 to 19.1)  0.69 3.8 (–11.8 to 19.5) 0.63
Total blood leukocyte count/µL PM2.5, 22.3 µg/m3 544 (104 to 983) 0.02 451 (40.5 to 860) 0.03
PM10, 39.2 µg/m3 577 (79.8 to 1,075) 0.02 512 (45.2 to 979) 0.03
Carbon load, 0.25 µm2 760 (290 to 1,230) 0.002 687 (224 to 1,150) 0.005
Neutrophils/µL PM2.5, 22.3 µg/m3 318 (18.4 to 618) 0.04 278 (–2.25 to 558) 0.05
PM10, 39.2 µg/m3 378 (40.4 to 716) 0.03 360 (42.8 to 668) 0.03
Carbon load, 0.25 µm2 353 (33.1 to 673) 0.03 294 (–20.0 to 609) 0.07
Lymphocytes/µL PM2.5, 22.3 µg/m3 196 (35.7 to 356) 0.02 147 (–1.0 to 294) 0.05
PM10, 39.2 µg/m3 160 (–23.5 to 343) 0.09 110 (–60.1 to 280) 0.21
Carbon load, 0.25 µm2 199 (46.5 to 351) 0.01 221 (72.2 to 370) 0.005
Platelets ×103/µL PM2.5, 22.3 µg/m3 –2.7 (–16.5 to 11.0) 0.70 –4.3 (–17.3 to 8.8) 0.52
PM10, 39.2 µg/m3 0.7 (–14.9 to 16.2) 0.93 –0.7 (–15.8 to 14.3) 0.92
Carbon load, 0.25 µm2 13.0 (–1.6 to 27.5) 0.09 14.1 (–0.3 to 28.5) 0.06
Differences calculated for an IQR increase in exposure variables,
aAdjusted for significant (p < 0.10) covariates (see text) identified by stepwise regression. Covariates considered for entry in the model were age, sex, BMI, socioeconomic status, out-
door temperature, time in traffic on day of exam, means of transportation to the exam, time in hospital before blood draw, hour of blood draw, use of alcohol, exposure to environmental 
tobacco smoke, blood glucose level, glycated hemoglobin, menopausal status, oral contraception, use of statins, use of ACE inhibitors, and use of antiplatelet medication. Type of 
diabetes was forced into all models. 
Figure 3. Platelet function and blood leukocytes. (A, C) Pearson correlations between recent exposure 
(PM10 measured at the study site 2 hr before clinical examination) and platelet function (A) or blood leuko-
cyte count (C). (B, D) Spearman rank correlations between chronic exposure (as assessed by the carbon 
load of airway macrophages) and platelet function (B) or blood leukocyte count (D). Platelet function was 
assessed by PFA-100; decreases in closure time reflect platelet activation (i.e., prothrombotic tendency).
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changes in these presumably more susceptible 
subjects, possibly via systemic inflammation. 
Therefore, in the present study we combined 
personal markers of recent exposure (PM mea-
sured at the study site) and chronic exposure 
to PM as assessed by the carbon load of airway 
macrophages (Kulkarni et al. 2006).
Platelet activation, measured ex vivo with 
the PFA, allows a quantitative measure of plate-
let aggregation as the time required to close 
a small aperture in a biological active mem-
brane by relevant stimuli. The average PFA 
closure time in our well-controlled diabetic 
population was comparable with the closure 
time in healthy subjects reported in literature 
(Homoncik et al. 2000; Seyfert et al. 2007). 
Our study shows that the closure time cor-
related inversely with the ambient PM air pol-
lution concentration, measured 2 hr before 
the blood collection. Previously, we showed 
in an experimental study that the intratracheal 
instillation of diesel exhaust particles (DEP) 
in hamsters caused platelet activation within 
1 hr and a dose-dependent enhanced arterial 
or venous thrombus (Nemmar et al. 2003a). 
Recently, Lucking et al. (2008) showed in a 
controlled exposure experiment an associa-
tion between enhanced thrombus formation 
ex vivo and inhalation of DEP 2 hr after expo-
sure. The clinical significance of the associa-
tion we observed between platelet activation 
measured ex vivo and air pollution stems from 
prospective observations that a shorter closure 
time of the PFA-100 device predicts recurrent 
ischemic events in patients who underwent a 
percutaneous coronary intervention (Gianetti 
et al. 2006). In our study, an IQR increase 
of 39.2 µg/m3 in PM10 was associated with a 
decrease in the PFA closure time of 25 sec. If 
we compare this with the average effect of anti-
platelet medication, it appears that the magni-
tude of the pollution effect (–25 sec) is about 
two-thirds (in the opposite direction) of that 
caused by the antiplatelet medication (36 sec). 
Intake of a daily dose of 75 mg aspirin during 
2 weeks caused an increase in the median PFA 
closure time of 30 sec in 10 healthy individuals 
(Ahmed et al. 2009). Similarly, in a population 
of 34 patients with type 2 diabetes, the mean 
PFA closure time significantly increased by 
57 sec after daily intake of 100 mg aspirin dur-
ing 1 week (Abaci et al. 2005).
We also documented systemic inflamma-
tory effects because we found a positive associa-
tion between the number of blood leukocytes 
and both recent and chronic exposure to PM 
air pollution. Mukae et al. (2001) showed in 
rabbits that repeated exposure to ambient PM10 
caused an accelerated release of immature poly-
morphonuclear leukocytes from the bone mar-
row. The magnitude of the stimulation of the 
bone marrow by PM10 was related to the quan-
tity of particles phagocytosed by alveolar mac-
rophages. Our findings that the carbon load of 
airway macrophages is associated with increases 
in blood leukocytes are in line with these exper-
imental findings. Long-term changes in leuko-
cyte counts in association with PM have also 
been investigated in human epidemiologic stud-
ies. Recent observations of the Third National 
Health and Nutrition Examination Survey 
showed a positive association between chronic 
(1 year) exposure to PM10 and blood leukocyte 
counts (Chen and Schwartz 2008). A study of 
39 Japanese men traveling to Antarctica, an 
area with low exposure to PM, showed a 17% 
decrease in leukocyte counts (Sakai et al. 2004).
This study is novel in that it suggests that 
persons with diabetes, a condition associated 
with chronic inflammation, may have a short-
term inflammatory response to recent PM air 
pollution, in addition to the effect of chronic 
exposure as assessed by the carbon load of air-
way macrophages. In persons without diabe-
tes, studies looking for short-term changes in 
leukocyte counts in relation to air pollution 
have given inconclusive results. Two stud-
ies that reported significant results for leu-
kocyte counts had opposite findings (Ghio 
et al. 2003; Schwartz 2001), and other studies 
reported null associations (Holgate et al. 2003; 
Pope et al. 2004; Seaton et al. 1999).
It has been shown that chronic inflam-
mation is involved in the development of 
atherosclerosis (Ross 1999). Chronic exposure 
to PM leading to systemic inflammation might 
therefore also play a role in the development of 
atherosclerosis. Exposing apolipoprotein E–null 
mice for 6 months to an equivalent concen-
tration of 15.2 µg/m3 PM2.5 over a lifetime, 
Sun et al. (2005) found that transverse sections 
of abdominal aorta increased in percentage 
plaque area compared with mice exposed to 
filtered air. Suwa et al. (2002) showed in rab-
bits that repeated exposure to PM10 was associ-
ated with both systemic inflammation and the 
progression of the atherosclerotic process, the 
extent of which correlated with the extent of 
PM10 phagocytosed by alveolar macrophages. 
Chronic inflammation is more prominent in 
type 2 diabetes than in persons with type 1 
diabetes. However, we did not find evidence 
of a higher sensitivity to air pollution–induced 
effects on platelet function or leukocyte distri-
bution in persons with type 2 diabetes com-
pared with their type 1 counterparts. O’Neill 
et al. (2005) found a stronger association 
between endothelial function and PM air pol-
lution in type 2 compared with type 1 diabe-
tes. In our study, patients had well-controlled 
glycated hemoglobin levels, which averaged 
7.4%. Moreover, insulin use in persons with 
type 2 diabetes was high.
We did not observe a link between leu-
kocyte counts and platelet activation. This 
suggests that PM may have effects on platelet 
function independently of systemic inflamma-
tion. In experimental conditions using DEP, 
Nemmar et al. (2003b) showed a prothrom-
botic tendency and activation of circulating 
blood platelets, as well as lung inflammation, 
which persisted up to 24 hr after instilla-
tion of DEP in hamsters. However, the pro-
thrombotic tendency observed 1 hr after DEP 
exposure did not appear to correlate with pul-
monary inflammation (Nemmar et al. 2003b).
Our study has limitations. Observational 
studies do not prove causality, even when expo-
sure is measured on an individual level. Recent 
exposure to PM was based on measurements 
at the hospital. We modeled PM data but no 
Table 3. Change in platelet function and in total or differential blood leukocyte counts and platelet count for an IQR increase in recent outdoor PM10 concentra-
tions and in carbon load of airway macrophages (combined analysis).
End point Exposure marker, IQR
Age-adjusted  
difference (95% CI) p-Value
Difference adjusted for 
significant covariates (95% CI)a p-Value
PFA-100 closure time (sec) PM10, 39.2 µg/m3 –18.8 (–38.4 to 0.75) 0.06 –25.4 (–44.4 to –6.3) 0.01
Carbon load, 0.25 µm2 2.1 (–13.5 to 17.7) 0.79 2.8 (–12.2 to 17.7) 0.72
Total blood leukocyte count/µL PM10, 39.2 µg/m3 770 (249 to 1291) 0.005 737 (239 to 1,236) 0.005
Carbon load, 0.25 µm2 806 (356 to 1,255) 0.0008 747 (303 to 1,190) 0.002
Neutrophils/µL PM10, 39.2 µg/m3 462 (102 to 821) 0.01 451 (109 to 793) 0.01
Carbon load, 0.25 µm2 381 (70.4 to 691) 0.02 331 (26.5 to 635) 0.04
Lymphocytes/µL PM10, 39.2 µg/m3 245 (75.4 to 414) 0.006 220 (58.0 to 382) 0.01
Carbon load, 0.25 µm2 213 (67.3 to 360) 0.006 242 (97.9 to 386) 0.002
Platelets ×103/µL PM10, 39.2 µg/m3 9.2 (–7.7 to 26.1) 0.29 8.8 (–7.6 to 25.1) 0.30
Carbon load, 0.25 µm2 13.5 (–1.1 to 28.1) 0.07 14.7 (0.29 to 29.2)  0.05
aAdjusted for significant (p < 0.10) covariates (see text) identified by stepwise regression. Covariates considered for entry in the model were age, sex, BMI, socioeconomic status, 
outdoor temperature, time in traffic on day of exam, means of transportation to exam, time in hospital before blood draw, hour of blood draw, use of alcohol, exposure to environmental 
tobacco smoke, blood glucose level, glycated hemoglobin, menopausal status, oral contraception, use of statins, use of ACE inhibitors, and use of antiplatelet medication. Type of dia-
betes was forced into all models.Jacobs et al.
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personalized exposure measurements 24 hr 
before blood draw. The carbon load of airway 
macrophages may not reflect the load of carbon 
in more distal alveolar cells, because sputum 
induction samples macrophages from the larger 
airways (Alexis et al. 2001). In adults, however, 
the distribution of PM from the environment 
in bronchial macrophages is nearly identical 
to that in alveolar macrophages (Fireman et al. 
2004; Lay et al. 1998). Our limited success 
rate of 58% for sputum induction may have 
introduced bias, but we found no differences 
in any other measured variables between those 
from whom sputum was induced successfully 
and those from whom it was not. Because 
the method used to assess the carbon load of 
50 airway macrophages per persons is labor 
intensive, our study sample did not include 
a very large number of participants, but this 
group size has been shown to be relevant when 
using this surrogate of personal exposure to 
PM (Kulkarni et al. 2006).
The carbon load in airway macrophages 
was associated with modeled 6-month average 
PM10 exposure at the patient’s home. However, 
the blood leukocyte count was not significantly 
associated with the modeled 6-month average 
PM10 concentration, although it was with the 
carbon load of airway macrophages. This sug-
gests that the latter biomarker of chronic expo-
sure might be a better reflection of personal 
exposure to PM. For the modeled previous 
day, week, month, 3-month, and annual aver-
age PM10 at the patient’s residence, we found 
no correlations (p ≥ 0.15) with the carbon load 
of airway macrophages.
Our findings have important implications 
for understanding the biological mechanisms 
of air pollution on cardiovascular health and 
its clinical relevance, because both a pro-
thrombotic tendency and systemic inflamma-
tion play an important role in atherosclerosis 
and cardiovascular disease. The clinical rele-
vance of our findings in persons with diabetes 
is evident from the observation that a realistic 
increase in recent PM air pollution exposure 
was associated with a change in platelet func-
tion toward a greater prothrombotic tendency. 
The magnitude of this change was about two-
thirds (in opposite direction) of the average 
effect of antiplatelet medication.
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